Gennaro A. Remington: The Science and Practice of Pharmacy. 19th ed. Lippincott: Williams & Wilkins, 1996.

Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.

Goldwaser I, Li J, Gershonov E, et al. L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo. J Biol Chem 1999;274:26617-24. View abstract.

Aharon Y, Mevorach M, Shamoon H. Vanadyl sulfate does not enhance insulin action in patients with type 1 diabetes. Diabetes Care 1998;21:2194-5.

Klaassen CD, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons. fifth ed. New York: McGraw-Hill, 1996.

Malabu UH, Dryden S, McCarthy HD, et al. Effects of chronic vanadate administration in the STZ-induced diabetic rat. Diabetes 1994;43:9-15. View abstract.

Bishayee A, Karmakar R, Mandal A, et al. Vanadium mediated chemoprotection against chemical hepatocarcinogenesis in rats: haematological and histological characteristics. Eur J Cancer Prev 1997;6:58-70. View abstract.

Chakraborty A, Chatterjee M. Enhanced erythropoietin and suppression of gamma-glutamyl-transpeptidase (GGT) activity in murine lymphoma following administration of vanadium. Neoplasma 1994;41:291-6. View abstract.

Domingo JL, Sanchez DJ, Gomez M, et al. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side effects. Vet Human Toxicol 1993;35:495-500. View abstract.

Oster MH, Llobet JM, Domingo JL, et al. Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects. Toxicology 1993;83:115-30. View abstract.

Stern A, Yin X, Tsang SS, et al. Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 1993;71:103-12. View abstract.

Sitprija V, Tungsanga K, Tosukhowong P, et al. Metabolic problems in northeastern Thailand: possible role of vanadium. Mineral Electrolyte Metab 1998;19:51-6. View abstract.

Domingo JL, Gomez M, Llobet JM, et al. Oral vanadium administration to streptozocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used. Toxicology 1991;66:279-87. View abstract.

Leonard A, Gerber GB. Mutagenicity, carcinogenicity and teratogenicity of vanadium Compounds. Mutat Res 1994;317:81-8. View abstract.

Funakoshi T, Shimada H, Kojima S, et al. Anticoagulant action of vanadate. Chem Pharmaceut Bull 1992;40:174-6. View abstract.

Halberstam M, Cohen N, Shlimovich P, et al. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes 1996;45:659-66. View abstract.

Cohen N, Halberstam M, Shlimovich P, et al. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1995;95:2501-9. View abstract.

Boden G, Chen X, Ruiz J, et al. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 1996;45:1130-5. View abstract.

Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002. Available at: www.nap.edu/books/0309072794/html/.

Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003;26:1277-94. View abstract.

Goldfine AB, Simonson DC, Folli F, et al. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 1995;80:3311-20. View abstract.

Cusi K, Cukier S, DeFronzo RA, et al. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metab 2001;86:1410-7. View abstract.

Kelly, G. S. Insulin resistance: lifestyle and nutritional interventions. Altern.Med Rev 2000;5(2):109-132. View abstract.

Nahas, R. and Moher, M. Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam.Physician 2009;55(6):591-596. View abstract.

Badmaev, V., Prakash, S., and Majeed, M. Vanadium: a review of its potential role in the fight against diabetes. J Altern Complement Med 1999;5(3):273-291. View abstract.

Goldfine, A. B., Patti, M. E., Zuberi, L., Goldstein, B. J., LeBlanc, R., Landaker, E. J., Jiang, Z. Y., Willsky, G. R., and Kahn, C. R. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism 2000;49(3):400-410. View abstract.

Beliaeva, N. F., Gorodetskii, V. K., Tochilkin, A. I., Golubev, M. A., Semenova, N. V., and Kovel'man, I. R. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus]. Vopr.Med Khim. 2000;46(4):344-360. View abstract.

Sakurai, H., Yasui, H., and Adachi, Y. The therapeutic potential of insulin-mimetic vanadium complexes. Expert.Opin Investig.Drugs 2003;12(7):1189-1203. View abstract.

Henquin, J. C. and Brichard, S. M. [Role of vanadium in the treatment of diabetes mellitus. Experimental data and clinical applications]. Presse Med 6-27-1992;21(24):1100-1101. View abstract.

Scior, T., Guevara-Garcia, A., Bernard, P., Do, Q. T., Domeyer, D., and Laufer, S. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review. Mini.Rev Med Chem 2005;5(11):995-1008. View abstract.

Tubek, S. Role of trace elements in primary arterial hypertension: is mineral water style or prophylaxis? Biol.Trace Elem.Res 2006;114(1-3):1-5. View abstract.

Bradley, R., Oberg, E. B., Calabrese, C., and Standish, L. J. Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J Altern.Complement Med. 2007;13(1):159-175. View abstract.

Chakraborty, T., Chatterjee, A., Rana, A., Rana, B., Palanisamy, A., Madhappan, R., and Chatterjee, M. Suppression of early stages of neoplastic transformation in a two-stage chemical hepatocarcinogenesis model: supplementation of vanadium, a dietary micronutrient, limits cell proliferation and inhibits the formations of 8-hydroxy-2'-deoxyguanosines and DNA strand-breaks in the liver of sprague-dawley rats. Nutr Cancer 2007;59(2):228-247. View abstract.

Smith, D. M., Pickering, R. M., and Lewith, G. T. A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus. QJM. 2008;101(5):351-358. View abstract.

Darvesh, A. S. and Bishayee, A. Selenium in the prevention and treatment of hepatocellular carcinoma. Anticancer Agents Med Chem 2010;10(4):338-345. View abstract.

Min, J. A., Lee, K., and Ki, D. J. The application of minerals in managing alcohol hangover: a preliminary review. Curr Drug Abuse Rev 2010;3(2):110-115. View abstract.

Sakurai, H., Katoh, A., Kiss, T., Jakusch, T., and Hattori, M. Metallo-allixinate complexes with anti-diabetic and anti-metabolic syndrome activities. Metallomics. 10-1-2010;2(10):670-682. View abstract.

Hosokawa, S. and Yoshida, O. Vanadium in chronic hemodialysis patients. Int J Artif.Organs 1990;13(4):197-199. View abstract.

Mancinella, A. [Vanadium, an indispensable trace element in living organisms. Current data on biochemical, metabolic levels and therapeutic doses]. Clin Ter. 1993;142(3):251-255. View abstract.

Scheen, A. J. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs 1997;54(3):355-368. View abstract.

Shi, S. J., Preuss, H. G., Abernethy, D. R., Li, X., Jarrell, S. T., and Andrawis, N. S. Elevated blood pressure in spontaneously hypertensive rats consuming a high sucrose diet is associated with elevated angiotensin II and is reversed by vanadium. J Hypertens. 1997;15(8):857-862. View abstract.

Cunningham, J. J. Micronutrients as nutriceutical interventions in diabetes mellitus. J Am Coll.Nutr 1998;17(1):7-10. View abstract.

Neyrolles, N., Blickle, J. F., and Brogard, J. M. [New therapies in type 2 diabetes]. Ann Endocrinol.(Paris) 1998;59(2):67-77. View abstract.

Shamberger, R. J. The insulin-like effects of vanadium. J Adv Med 1996;(9):121-131.

Jacques-Camarena O, et al. Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance. Ann Nutr Metab. 2008;53(3-4):195-198. View abstract.

Gruzewska K, Michno A, Pawelczyk T, Bielarczyk H. Essentiality and toxicity of vanadium supplements in health and pathology. J Physiol Pharmacol. 2014;65(5):603-611. View abstract.

Peat F, Coomber R, Rana A, Vince A. Vanadium allergy following total knee arthroplasty. BMJ Case Rep 2018;2018. pii: bcr-2017-222092. doi: 10.1136/bcr-2017-222092. View abstract.

Jin S, Xia W, Jiang Y, et al. Urinary vanadium concentration in relation to premature rupture of membranes: A birth cohort study. Chemosphere 2018;210:1035-41. doi: 10.1016/j.chemosphere.2018.07.110. View abstract.

Garcia-Nunez I, Algaba-Marmol MA, Suarez-Vergara M, et al. Vanadium contact dermatitis: case report and studies performed. Contact Dermatitis 2019;80(2):127-8. View abstract.

Zhou Y, Zhu Q, Ma W, et al. Prenatal vanadium exposure, cytokine expression, and fetal growth: a gender-specific analysis in Shanghai MCPC study. Sci Total Environ 2019;685:1152-9. View abstract.

Jiang S, Zhou S, Liu H, et al. Concentrations of vanadium in urine with hypertension prevalence and blood pressure levels. Ecotoxicol Environ Saf 2021;213:112028. View abstract.

Zhang W, Chen H, Zeng Q, Xu S, Xia W, Li Y. Prenatal and postnatal exposure to vanadium and the immune function of children. J Trace Elem Med Biol 2021;67:126787. View abstract.